actAVA joins OpenAI Partner Network as Select Partner

actAVA said it has been named an OpenAI Select Partner, expanding its work with OpenAI to help healthcare organizations move AI into production with stronger governance and audit controls. The partnership is aimed at regulated health systems using AI for high-stakes administrative workflows such as prior authorization and utilization management.

Why it matters: - actAVA is targeting a core blocker in healthcare AI: how to move from pilots to production without losing control over governance, compliance, and auditability. - The partnership with OpenAI is meant to help health systems deploy frontier models in regulated settings while keeping safety and oversight in place. - The company is positioning KORA as infrastructure for agentic AI in administrative workflows that affect cost, operations, and patient access.

What happened: - actAVA announced on August 8, 2026 that it has been named an OpenAI Select Partner within the OpenAI Partner Network. - The OpenAI Partner Network connects partners that build, sell, and deliver AI solutions with OpenAI. - actAVA said it will continue working with OpenAI to help healthcare organizations build, deploy, and scale AI responsibly. - Kevin Riley, co-founder and CEO of actAVA, said the partnership gives the company a way to pair OpenAI’s models with the guardrails clinical operations require.

The details: - actAVA describes itself as a healthcare workflow-to-model learning platform. - The company said its KORA platform combines frontier model capabilities with governance, testing, and audit controls for regulated healthcare environments. - KORA is designed to support agentic AI across prior authorization, utilization management, care management, and other administrative workflows. - actAVA said it supports payers, providers, and health systems through four KORA capabilities: Plan & Build, Test & Measure, Optimize & Scale, and Govern & Audit. - The company said it published χ-Bench, a long-horizon healthcare benchmark for AI agents developed with more than 20 hospitals and universities. - actAVA said it also delivers CHRYSO, a compliance product that automates requirements across the NIST AI Risk Management Framework, HIPAA, and CMS standards. - The company said it works with institutions including Johns Hopkins Medicine. - actAVA said it is HIPAA compliant and SOC 2 certified. - The platform allows teams to build and manage agents using private or anonymized models from leading AI providers. - The OpenAI Partner Network provides resources, enablement, and support to help enterprises adopt OpenAI frontier models and products and turn them into measurable impact. - More information about the network is available here. - actAVA’s social links include LinkedIn and X.

Between the lines: - The announcement shows actAVA leaning into the regulated-healthcare niche, where model performance alone is not enough. - Governance, testing, audit trails, and compliance tooling are the differentiators the company is emphasizing. - The partnership also suggests OpenAI wants more distribution through vertical specialists that can package models into workflow-ready products.

What's next: - actAVA said it plans to deepen its OpenAI-related offerings, including expanding model coverage within KORA. - The company also plans to keep investing in healthcare-team enablement and customer deployments. - actAVA said it wants to help customers translate AI ambition into business and patient outcomes.

The bottom line: - actAVA is using its OpenAI Select Partner status to push a regulated-care AI strategy built around deployment, governance, and measurable operational impact.